Levisonics Inc, based in New Orleans, LA, is revolutionizing haemostatic assays with their next-generation platform for bleeding thrombosis risk testing. Their technology requires only a fraction of the sample volume, making critical diagnostics accessible for neonates, young patients, and home care settings.
With a focus on pediatrics and neonatal care, Levisonics Inc addresses the challenge of large blood draws by offering a solution that enables medical professionals to perform haemostatic assays with ease. Additionally, their technology provides a reliable and convenient option for self-monitoring anticoagulant dosage at home, reducing the risk of overdose and adverse drug events.
Generated from the website